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Abstract 
Background: Malaria intervention in Ethiopia has been strengthened significantly in the past decade. The Ethiopian 
government recently stratified the country based upon annual parasite incidence into malaria free, low, moderate 
and high transmission strata. Districts with low transmission were targeted for indigenous transmission elimination. 
Surveillance on malaria disease incidence is needed for planning control and elimination efforts.
Methods: Clinical malaria was monitored prospectively in health facilities in Jimma town, Oromia Region, southwest‑
ern Ethiopia from July 2014 to June 2015. Seasonal cross‑sectional parasite prevalence surveys in local communities 
were conducted in 2014 and 2015 in eight kebeles. Case report forms were administered to obtain sociodemographic 
and epidemiological information from patients.
Results: A total of 1434 suspected malaria cases were examined from the health facilities and 428 confirmed malaria 
cases were found. Among them, 327 (76.4 %) cases were Plasmodium vivax, 97 (22.7 %) were Plasmodium falciparum, 
and 4 (0.9 %) were mixed infection of P. vivax and P. falciparum. The annual malaria incidence rate was 1.7 cases per 
1000 people at risk. Parasite prevalence in the community was less than 3 %. Household ownership of insecticide‑
treated nets (ITNs) was 47.3 % (1173/2479) and ITN usage was 37.9 %. All ITNs were long‑lasting insecticidal nets, and 
repellent use was not found in the study area. Being male and traveling were the significant risk factors for P. falcipa-
rum malaria. For P. vivax malaria, risk factors included occupation and history of malaria illness during the preceding 
30 days.
Conclusion: Epidemiological evidence suggested low clinical malaria incidence and prevalence in Jimma town. 
More aggressive measures may be needed to further suppress vivax transmission. Strategies should be planned tar‑
geting sustained control and elimination.
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Background
Ethiopia is one of the few countries in Africa where Plas-
modium vivax and Plasmodium falciparum coexist [1, 2]. 
It is also one of the few African countries with a policy of 
providing malaria prevention and control services includ-
ing malaria diagnosis and treatment, insecticide-treated 
bed nets (ITNs), and indoor residual spray (IRS) free of 
charge [3–6]. This policy ensures that malaria interven-
tions reach the poor, and in turn enables them to increase 
economic productivity [4]. In Ethiopia, major malaria 
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intervention scale-up efforts began in 2004/2005 with the 
introduction of artemisinin-based combination therapy 
(ACT) as the first-line treatment of P. falciparum malaria. 
ACT has been free of charge for all ages in the public 
sector since then [3–5]. IRS campaigns have targeted 
epidemic-prone areas, and IRS coverage has reached to 
37 % of the at-risk population in 2013 [4–6]. Long-lasting 
insecticidal nets (LLINs) have been distributed free of 
charge to the entire population through mass campaigns 
to step up vector control and prevention since 2006 [3, 4]. 
In 2008, the Ethiopian government distributed 20.4 mil-
lion LLINs, and 11.2 million were replaced in 2010 and 
7 million in 2011 [3, 4]. The combined improvement in 
coverage of essential interventions has coincided with a 
considerable reduction in malaria morbidity and mortal-
ity as well as epidemic episodes and affected areas. While 
no epidemics have been reported in the country since 
2004 [7], a comprehensive longitudinal study showed that 
malaria remains a major public health problem in Ethio-
pia [8, 9].
The latest National Malaria Strategic Plan of Ethio-
pia stratified districts into malaria free, low, moderate 
and high transmission areas based upon annual parasite 
incidence [4, 10]. An ambitious goal was set to eliminate 
indigenous transmission in low transmission areas [4, 
10]. In some districts where malaria control is shifted 
to elimination, changes have been made in the malaria 
treatment guideline. For example, a single low-dose 
primaquine is added to the artemether-lumefantrine 
(Coartem®) treatment regimen for P. falciparum to kill 
gametocytes and reduce malaria transmission. A 14-day 
course of primaquine is added to the chloroquine treat-
ment regimen for radical cure of P. vivax malaria in 
low transmission area [10]. In the past 10  years, IRS 
has been performed on an annual basis and LLINs 
have been distributed to all residents in Jimma town 
free of charge [4]. However, data on the current cover-
age of interventions (e.g., LLIN ownership and popula-
tion coverage), epidemiological characteristics (e.g., age 
and gender distribution) and clinical malaria risk fac-
tors broadly in Ethiopia as well as in local areas are still 
lacking.
The present study determined the current epidemio-
logical characteristics of malaria in urban and suburban 
sites of southwestern Ethiopia. Prospective passive case 
detection was conducted in health centers and district 
hospitals to determine clinical malaria incidence in par-
allel with cross-sectional surveys to determine para-
site prevalence in the community. This information on 
malaria epidemiology can inform malaria control and 
elimination strategies in Ethiopia.
Methods
Study area
The study was conducted in Jimma town (7°41′ N, 36°50′ 
E, 1710–1800 m above sea level) in a highland low-trans-
mission epidemic-prone area in Oromia Region, south-
western Ethiopia (Fig. 1). The population of Jimma town 
was about 176,500 in 2015. Jimma town has a warm cli-
mate with a mean annual temperature of 23  °C, a mean 
annual maximum temperature of 27  °C, and a mean 
annual minimum temperature of 19 °C. The mean annual 
precipitation is about 1500  mm, with one rainy season 
from May to September. December and January are the 
driest months.
Passive malaria case detection (PCD)
PCD was conducted prospectively in all public health 
centres and hospitals in Jimma town including Becho 
Bore Health Centre, Jimma Health Centre, Jimma 
Higher Two Health Centre, Mendera Kochi Health Cen-
tre, and Shenen Gibe Hospital, except Jimma Univer-
sity Special Hospital (Fig.  1). Jimma University Special 
Hospital usually accepts referred severe malaria cases, 
to avoid double count, malaria cases from this hospi-
tal were not included in data analysis. These are all the 
government-run malaria treatment centres and hospitals. 
A clinical malaria case is defined as an individual with 
malaria-related symptoms (fever, i.e., axillary tempera-
ture ≥37.5 °C, chills, severe malaise, headache or vomit-
ing) at the time of examination or 1–2 days prior to the 
examination, with a Plasmodium positive blood smear 
[11, 12]. All febrile patients with malaria-like symptoms 
attending these health facilities were enrolled into this 
study upon the signing of consent or assent forms for 
minors. Standard case report forms were used to col-
lect the following information from each patient: village 
of residency, demographic characteristics, occupation, 
education level, clinical symptoms, blood hemoglobin 
level, history of malaria in the preceding 30 days, history 
of travel in the 2 weeks preceding the clinic visit, history 
of fever, treatment drug prescribed, and ownership and 
use of malaria prevention measures. If ITN was used, the 
types and usage (used or not during the preceding night) 
of ITN were recorded. Thick and thin blood smears were 
prepared for each patient. Slides were stained with 10 % 
Giemsa and examined microscopically by experienced 
laboratory technologists at the Medical Parasitology Lab-
oratory of Jimma University. Species were identified and 
parasites were counted against 200 leukocytes. All posi-
tive slides and 10  % of negative slides were reexamined 
blindly by another senior laboratory technologist. PCD 
was conducted from July 2014 to June 2015 (Fig. 2).
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Cross‑sectional parasitological survey
Cross-sectional parasite prevalence surveys were con-
ducted three times in October 2014 (high-transmission 
season), March 2015 (end of high-transmission season), 
and August 2015 (end of low-transmission season), in 
eight kebeles (the smallest administrative unit in Ethiopia, 
equivalent to a district in a city) representing both urban 
and suburban settings (Figs. 1, 2). Households were ran-
domly selected from each kebele to maximize coverage 
so that the surveyed population would represent the 
eight kebeles. To avoid sampling bias, one volunteer was 
arbitrarily selected from each selected household for par-
ticipation of this study. Peripheral blood was collected by 
the standard finger-prick method using disposable lan-
cets in October 2014, March and August 2015, respec-
tively. Thick and thin smears were prepared. Slides were 
stained and examined at the Jimma University Special-
ized Hospital laboratory according to standard World 
Health Organization procedures. Smears were stained 
with Giemsa solution, and examined microscopically 
at a magnification of 100× by experienced laboratory 
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Fig. 2 Chronology of the study: demographic survey, cross‑sectional parasite prevalence survey and passive case surveillance
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control for slide reading was implemented as described 
above. Each study participant found positive for malaria 
was referred to a nearby health facility for treatment, 
according to the national malaria diagnosis and treat-
ment guidelines.
A subset of the blood samples was subjected to further 
PCR analysis to confirm parasite infection and to identify 
the parasite species [13–15]. The initially plan was to do 
PCR on all blood samples, due to the zero prevalence rate 
detected by microscopy, PCR was only done on randomly 
selected samples after the second round survey.
Sample size was estimated based on the binomial 
model. Because the prevalence of malaria was low in the 
area, an estimate of 10  % prevalence was used for the 
peak-transmission season and 5 % for the low-transmis-
sion season in sample size determination [13, 16]. The 
resulting sample sizes were 559 persons for the peak-
transmission season and 386 for the low-transmission 
season for prevalence estimation at precision level of 
5  %. For the PCR method, assuming ≤5  % prevalence 
based on microscopic results, with a Type I error of 5 % 
and population (blood samples) size of 850, 218 samples 
could detect a marginal error of 2.5 %. To allow for 10 % 
PCR failure rate, 240 samples is enough.
Demographic survey
The demographic survey was conducted in the same 
eight kebeles as the parasitological surveys (Figs.  1, 2). 
Households were randomly selected from each kebele 
to maximize coverage so that the surveyed population 
would represent the eight kebeles. All individuals living in 
the selected households were included in the study. For 
all consenting individuals, demographic characteristics 
(age, sex, occupation, and education level) and informa-
tion on preventive measures (ITN, IRS, repellent, and 
others) were collected through questionnaires. The sur-
vey was conducted from May to June 2014. Information 
collected on ITNs included ITN ownership, type, and 
usage. The total population at each kebeles in Jimma was 
obtained from the Central Statistical Agency of Ethiopia 
based on 2015 demographic projections. Household ITN 
ownership was calculated as percentage of households 
that owns at least one ITN based on demographic survey.
Data analysis
The density of parasitaemia was expressed as the number 
of asexual Plasmodium per microlitre of blood, assum-
ing a leukocyte count of 8000 per microlitre. Annual 
malaria incidence rate was calculated as the number of 
cases per 1000 population at risk. Parasite prevalence 
rate was calculated as the number of infected individu-
als per 100 people. The incidence rate was stratified into 
three age groups: age < 5, 5 ≤ age < 15, and ≥15 years. 
Differences in sex-, age-, and occupation-specific inci-
dence rates were analysed using χ2 test and odds ratios 
(ORs) were calculated for different categories separately 
against their respective reference group. Risk factors of 
clinical malaria were analysed using multivariate nominal 
logistic regression analysis. Risk factors included age, sex, 
occupation, history of malaria in the preceding 30 days, 
history of travel in the preceding 2 weeks, and preventive 
measure usage. Risk factor analysis was done separately 
for P. falciparum and P. vivax. SPSS (IBM Corporation, 
Armonk, New York, USA) was used for data analysis.
Ethical statement
Ethical clearance was obtained from the Institutional 
Review Boards (IRBs) of Jimma University, Ethiopia, and 
the University of California at Irvine, USA. Written con-
sent (assent for children under 18  years) was obtained 
from heads of households and study participants. All 
cases with a history of fever in the preceding 3 days, as 
well as those with fever on examination and a positive 
test for malaria parasite in the blood film examination, 
were offered anti-malarial treatment by physicians from 
Jimma University as per national malaria diagnosis and 
treatment guidelines. Infants younger than 6  months 
and individuals who were unwilling to participate were 
excluded from the study.
Results
Epidemiological characteristics of clinical malaria
A total of 1434 suspected cases were examined and clini-
cal malaria was confirmed in 428 cases. Among the con-
firmed cases, 327 (76.4 %) were P. vivax, 97 (22.7 %) were 
P. falciparum, and four (0.9 %) were mixed infections of 
P. vivax and P. falciparum. No Plasmodium malariae or 
Plasmodium ovale was detected. Demographic informa-
tion was obtained from 10,119 individuals comprising 
5278 (52.2 %) females and 4841 (47.8 %) males, with an 
average age of 20.7 years (Additional file 1). Among the 
confirmed malaria cases, 299 resided within the eight vil-
lages where demographic information was collected and 
available. Among these cases, 224 (74.9 %) were P. vivax, 
71 (23.7 %) were P. falciparum, and 4 (1.3 %) were mixed 
infections of P. vivax and P. falciparum. The annual 
malaria incidence rate was 1.7 cases per 1000 people at 
risk (Table 1).
Total number of case report forms and confirmed 
malaria cases decreased monotonously from July 2014 to 
June 2015 (Fig.  3). Plasmodium falciparum malaria was 
seasonal and was mainly observed from July to October 
2014, but the seasonality in clinical P. vivax malaria was 
not obvious (Fig. 3). While males had significantly higher 
P. falciparum malaria incidence rates (OR = 1.68, 95 % CI 
[1.04, 2.71], P < 0.05) (Table 1) than females, there was no 
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gender difference in P. vivax malaria. Incidence rates did 
not vary by age for either malaria species (Table 1). There 
was a significant difference in P. vivax incidence rates 
among different occupation groups (Table  1). Trader 
and travellers had the lowest P. vivax incidence rate (0.53 
cases per 1000 people year), whereas office workers and 
teachers had the highest incidence rate compared to the 
other groups (3.92 cases per 1000 people year; OR = 3.39, 
95 % CI [2.08, 5.50]). Although incidence rates of P. fal-
ciparum malaria varied substantially among occupation 
groups, the variation was not statistically significant due 
to small number of falciparum cases detected (Table 1).
Five categories of malaria preventive measures were 
included in the questionnaire: bed nets, indoor residual 
spraying (IRS), repellent, others, and none. The house-
hold ITN ownership rate (percentage of households that 
owns at least one ITN) was 47.3 % (1173/2479) and ITN 
usage rate (i.e., proportion of individuals who reported 
to use the net the night before the survey) was 37.5  %. 
All ITNs were LLINs, and no repellent use was found in 
the questionnaire survey. The use of LLIN was not sig-
nificantly associated with clinical malaria risk (Table  2). 
Travel during the preceding 14 days did not affect P. vivax 
malaria incidence, but it increased the likelihood of P. fal-
ciparum malaria by fourfolds (OR = 4.14, 95 % CI [2.11, 
8.14], P  <  0.001) (Table  2). On the other hand, having 
malaria during the preceding 30 days increased the likeli-
hood of P. vivax malaria by nearly threefolds (OR = 2.63, 
95 % CI [1.51, 4.57], P < 0.001) (Table 2).
Multiple logistic regression analysis indicated that male 
had marginally higher risk than females, and that people 
who travelled during the preceding 14 days had a signifi-
cantly higher risk of having P. falciparum malaria after 
adjusting for other risk factors (Additional file 2). For P. 
vivax malaria, being an office worker or teacher, or had 
malaria during the preceding 30 days were the significant 
risk factors (Additional file 3).
Table 1 Epidemiological characteristics of clinical malaria in Jimma town, southwestern Ethiopia
*, ** and *** represent significance at level of 0.05, 0.01 and 0.001, respectively
a Based on 2013 population and percentage was calculated based on the 2014 demographic surveys of 10,119 individuals
b Non-schooled children includes all children (<15 years) who are not attending any regular school
c Includes all students from kindergarten to college students
d Farmer, factory worker, construction worker, gardener, casual worker, and unemployed
Parameter Populationa P. vivax P. falciparum
Incidence rate Odds ratio (95 % CI) Incidence rate Odds ratio (95 % CI)
Overall 176,498 1.27 0.40
Gender
 Female (%) 52.16 1.33 1 0.30 1
 Male (%) 47.84 1.21 0.91 [0.70, 1.19] 0.51 1.68 [1.04, 2.71]*
Age (year)
 <5 (%) 14.64 1.32 1 0.46 1
 ≥5 and <15 (%) 25.04 1.45 1.10 [0.72, 1.68] 0.43 0.92 [0.45, 1.91]
 ≥15 (%) 60.32 1.18 0.90 [0.61, 1.32] 0.38 0.81 [0.42, 1.54]
Occupation
 Trader/traveler (%) 10.90 0.53 1 0.32 1
 Non‑schooled child (%)b 18.95 0.85 1.62 [0.78, 3.35] 0.27 0.86 [0.31, 2.43]
 Students (%)c 29.82 1.22 2.33 [1.19, 4.56]* 0.44 1.44 [0.57, 3.46]
 Housewife (%) 15.37 1.42 2.73 [1.36, 5.52]** 0.41 1.30 [0.48, 3.53]
 Farmer and worker (%)d 22.15 1.72 3.32 [1.70, 6.48]*** 0.55 1.73 [0.70, 4.30]















































Fig. 3 Monthly dynamics of number of case report forms and 
confirmed clinical malaria cases by parasite species in Jimma town, 
southwestern Ethiopia
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Parasite prevalence in cross‑sectional survey
In the cross-sectional survey low parasite prevalence 
was found consistently among the three sampling time 
points (Table  3). Overall, parasite prevalence was 0.8  % 
by microscope and 2.4 % by PCR. Microscopically identi-
fied parasite prevalence was about 2.7  % (0.8  % P. falci-
parum and 1.9 % P. vivax) during the high-transmission 
season in October 2014. Unfortunately, PCR was not 
done for this survey due to the loss of blood samples dur-
ing sample transportation. Microscopy did not identify 
any infection for the surveys conducted in March and 
August 2015, but PCR analysis detected a prevalence of 
2.6 and 1.7 %, respectively (Table 3). Overall, there were 
23 (56.1  %) P. vivax positive samples and 18 (43.9  %) P. 
falciparum positive samples in the three surveys. No P. 
malariae, P. ovale, or mixed infections were identified by 
either microscopy or PCR.
Discussion
With the support of the Global Fund to Fight AIDS, 
Tuberculosis and Malaria, the President’s Malaria 
Initiative and from the African national governments, 
there has been a massive scale-up of antimalarial inter-
ventions in the past decade. These interventions have led 
to wide-scale reductions in malaria morbidity and mor-
tality and have changed the landscape of malaria epide-
miology in Africa. For example, many studies have shown 
that household ITN ownership has reached more than 
80  % in Eastern Africa [17–19] and that the scaling-up 
of malaria control has greatly reduced malaria-related 
burdens [20–26]. Despite high coverage of ITNs and IRS, 
some areas, however, showed a resurgence of malaria in 
recent years [27–32]. This phenomenon could be linked 
to strong insecticide resistance in Anopheles mosquitoes 
[33–35]. Compare to findings from a previous study, par-
asite prevalence rate in Jimma has been reduced by more 
than 50 % in the last 5 years (5.2 % in 2010 vs. 2.5 % in 
2015). While it is a significant reduction in malaria prev-
alence, parasite species compositions are comparable 
between the two studies [8].
In this study, household ITN ownership in Jimma town 
was 47  % and usage was 38  %. These percentages were 
close to the national average [5] but far below the govern-
ment target of universal coverage of at-risk populations 
by 2015 [4]. ITN users in the study area had a slightly 
lower but insignificant risk of clinical malaria compared 
to those who did not use ITNs. This coincided with ear-
lier reports that suggested ITN use did not reduce P. 
falciparum prevalence [16, 32, 36]. The ineffectiveness 
of ITNs may be attributed to factors such as insecticide 
resistance [37–39], early biting and outdoor transmission 
[16, 29, 36]. In Jimma, Anopheles arabiensis is the major 
malaria vector [16, 37, 40, 41]. Previous blood-meal anal-
ysis in An. arabiensis in Ethiopia found that the human 
Table 2 Univariate analysis of risk factors of clinical malaria in Jimma town, south western Ethiopia
*, **, *** represent significant level of 0.05, 0.01 and 0.001, respectively
a Confirmed cases
Risk factor Case reported P. vivax P. falciparum
Casesa Odds ratio (95 %CI) Casesa Odds ratio (95 % CI)
Use of prevention measure
 Yes 661 152 1 47 1
 No 773 175 0.98 [0.77, 1.26] 50 0.90 [0.60, 1.36]
Use of ITN
 Used ITN 609 199 1 59 1
 Not available or not use 825 131 1.16 [0.90, 1.49] 37 1.19 [0.78, 1.82]
Travel during the preceding 14 days
 No, not traveled 1378 311 1 85 1
 Yes, traveled 56 16 1.37 [0.76, 2.48] 12 4.14 [2.11, 8.14]***
Malaria during the preceding 30 days
 No, no malaria 1380 304 1 91 1
 Yes, had malaria 54 23 2.63 [1.51, 4.57]*** 6 1.77 [0.74, 4.25]
Table 3 Microscopy- and  PCR-based parasite prevalence 
of  cross-sectional surveys in  Jimma town, south western 
Ethiopia
Pf Plasmodium falciparum; Pv Plasmodium vivax
Collection date Microscopy (%) Nested PCR (%)
Sample size Pf Pv Sample size Pf Pv
October, 2014 622 0.8 1.9 Not done
March, 2015 755 0 0 727 1.2 1.4
August, 2015 833 0 0  290 1.4 0.3
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blood index (HBI) and bovine blood index (BBI) were 
similar; i.e., the vector fed almost equally on human and 
animals [37, 40]. This implies that even if ITN usage by 
humans is 100  %, indoor prevention measures such as 
ITNs and IRS do not protect people who rest and work 
outdoor [37, 39, 40, 42].
Changes in age and gender distribution represent a 
common epidemiological shift in malaria-eliminating 
countries, where increasing proportions of adults and 
males were observed among all malaria cases regardless 
of malaria parasite species [43, 44]. In this study, males in 
the study area had higher clinical P. falciparum malaria 
incidence rates than females, consistent with previous 
studies [8, 45]. The reason for this is unclear, but it is pos-
sible that males may spend longer time outdoor during 
evening and thus expose more frequent to mosquito bit-
ing. Age is a malaria risk factor especially in areas of high 
transmission intensity [37, 43, 45–47]. In high-transmis-
sion settings, young children typically have the highest 
parasite prevalence and clinical incidence [12, 48–50], 
whereas in areas of very low transmission both children 
and adults are vulnerable groups [43, 44]. The finding 
that age was not a significant risk factor of malaria preva-
lence is consistent with the epidemiological situation in 
low transmission areas.
It is not surprising that a history of malaria illness in 
the preceding 30  days posed a risk for P. vivax malaria 
but not P. falciparum malaria. This was likely due to the 
relapse of vivax parasite arising from persistent liver 
stages of hypnozoites [51]. In the tropics, P. vivax relapse 
is a common phenomenon. This finding has critical 
implications in guiding malaria control and elimination 
in Ethiopia. For P. falciparum malaria, it seems that the 
current front-line treatment policy, e.g., first-line treat-
ment with ACT, is possibly effective and sufficient for the 
elimination of falciparum malaria, given the continuous 
decline in clinical falciparum malaria incidence [1]. By 
contrast, clinical P. vivax malaria remains unchanged in 
the study area. More aggressive treatment such as radi-
cal cure with primaquine may be needed to avoid relapse 
of vivax malaria. However, it is noteworthy that extreme 
caution must be taken when implement primaquine 
for radical cure of vivax malaria because primaquine 
may cause acute hemolysis in individuals with Glucose-
6-phosphate dehydrogenase (G6PD) deficiency, although 
Such effect may be less severe or absent if dosage was low 
[52].
It is interesting that occupation was found to be a 
risk factor for P. vivax malaria but not for P. falciparum 
malaria in the present study. Indoor workers such as 
teachers and office workers showed a four-fold higher 
risk of getting vivax malaria than outdoor workers. A 
possible explanation could be differential treatment-
seeking behavior as the office workers and teachers are 
financially capable of seeking health care at the health 
centres [9]. Although anti-malarial treatment is free in 
Ethiopia, all patients are required to pay clinical registra-
tion (~US $1.00) and laboratory test (~US $0.25 per test) 
fees. On the other hand, individuals who travelled in the 
preceding 14 days showed a high risk of getting falcipa-
rum malaria. This likely resulted from being exposed to 
P. falciparum in surrounding rural areas with high trans-
mission intensity [43, 44].
In this study, P. falciparum malaria was seasonal, how-
ever, seasonality in P. vivax malaria was not clear. The 
high number of clinical vivax cases from July to Septem-
ber in 2014 was inconsistent with entomological obser-
vations and rainfall patterns in the area, where the peak 
transmission season was expected to be from October to 
December [16]. Therefore, the declining trend in clini-
cal malaria from July 2014 to June 2015 may be an over-
all declining in malaria transmission in the area, but yet 
needs to be confirmed with long-term observations.
The limitation of this study is that malaria cases were 
collected only from government-run malaria treatment 
centres and hospitals of the study areas. By the govern-
ment policy, sales of anti-malarial drugs by private shops 
are prohibited, so self-treatment of malaria in Ethiopia 
is very unlikely. Malaria cases could have been underes-
timated because patients may seek treatments in other 
small private clinics that were not included here. Also, 
another major hospital, Jimma University Special Hospi-
tal that is specialized in treating severe malaria was not 
included. Although the number of malaria cases is known 
to be small and some case may have been reported from 
elsewhere, this may slightly influence the estimations of 
this study.
Conclusion
The urbanization process results in profound socio-
economic and landscape changes that generally reduce 
malaria transmission [53, 54]. However, population 
movement between urban areas and surrounding malari-
ous rural areas presents an important risk to residents in 
urban areas. In Ethiopia, where P. falciparum and P. vivax 
coexist, the effects of urbanization and human movement 
on the clinical disease incidence of these two species were 
not the same, and should be investigated further. Clinical 
malaria disease incidence and parasite prevalence data in 
Jimma town suggest very low transmission that could be 
targeted for elimination. Epidemiological studies and risk 
factor analysis suggest malaria control and elimination in 
urban settings where P. falciparum and P. vivax coexist 
require new strategies.
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